Conduit Pharmaceuticals Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 2.11 M | $144.51 K | 561.69% | 0.05% |
RHUMBLINE ADVISERS | 01/30/2025 | 1.03 M | $70.97 K | 5,034.01% | 0.03% |
BARCLAYS PLC | 02/13/2025 | 892.35 K | $61.00 K | 6.51% | 0.02% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 584.98 K | $40.13 K | 36.78% | 0.01% |
BLACKROCK, INC. | 02/07/2025 | 539.74 K | $37.03 K | -28.57% | 0.01% |
CITADEL ADVISORS LLC | 02/14/2025 | 526.27 K | $36.10 K | 177.00% | 0.01% |
VANGUARD GROUP INC | 02/11/2025 | 366.70 K | $25.30 K | 1.38% | 0.01% |
MORGAN STANLEY | 02/14/2025 | 261.51 K | $17.94 K | 42.45% | 0.01% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 260.76 K | $17.89 K | 414.16% | 0.01% |
NORTHERN TRUST CORP | 02/14/2025 | 186.18 K | $12.77 K | 0.73% | 0.00% |
FMR LLC | 02/13/2025 | 170.90 K | $11.72 K | 740.39% | 0.00% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 167.97 K | $11.52 K | 100.00% | 0.00% |
VIRTU FINANCIAL LLC | 02/11/2025 | 123.71 K | $8.00 K | 100.00% | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 88.70 K | $6.00 K | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 86.46 K | $5.97 K | 132.72% | 0.00% |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/10/2025 | 56.98 K | $3.91 K | 28.58% | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 53.11 K | $3.64 K | 0.00% | 0.00% |
CITIGROUP INC | 02/12/2025 | 44.85 K | $3.08 K | 168.79% | 0.00% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 42.70 K | $2.90 K | 138.43% | 0.00% |
ABEL HALL, LLC | 01/23/2025 | 40.02 K | $2.75 K | 100.00% | 0.00% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 28.19 K | $1.93 K | 128.74% | 0.00% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 27.91 K | $1.92 K | 100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 25.01 K | $1.72 K | 37.60% | 0.00% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 11.20 K | $768 | 100.00% | 0.00% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 9.64 K | $661 | 12.96% | 0.00% |
AMERITAS INVESTMENT PARTNERS, INC. | 02/13/2025 | 2.26 K | $155 | 0.00% | 0.00% |
STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 44 | $3 | 0.00% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
XTX TOPCO LTD | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
Conduit Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Conduit Pharmaceuticals Inc.. The most heavily invested institutionals were:
RHUMBLINE ADVISERS: 0
BlackRock, Inc.: 0
NEW YORK STATE COMMON RETIREMENT FUND: 0
Qube Research & Technologies Ltd: 2.11 M
BARCLAYS PLC: 892,350
GEODE CAPITAL MANAGEMENT, LLC: 584,984
0.21% of Conduit Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.77 M shares in the last 24 months. This purchase volume represents approximately $3.38 M in transactions.